VISIT US IN CHICAGO JUNE 2-4 AT BOOTH 2073!

Dr. Siegel on the Treatment of HPV-Associated Head and Neck Cancer

Robert Siegel, MD
Published: Friday, Jul 07, 2017



Robert Siegel, MD, chair, professor of medicine, director, Division of Hematology/Oncology, George Washington University, discusses the treatment for patients with HPV-associated head and neck cancer.

Many cases of head and neck cancer have become associated with HPV, explains Siegel. The implications of high-dose radiation are more consequential since the patients are younger.

Instead of using traditional chemotherapy and radiation regimens, standard doses of chemotherapy drugs have shown HPV-associated cancers shrink quicker, states Siegel.
 


Robert Siegel, MD, chair, professor of medicine, director, Division of Hematology/Oncology, George Washington University, discusses the treatment for patients with HPV-associated head and neck cancer.

Many cases of head and neck cancer have become associated with HPV, explains Siegel. The implications of high-dose radiation are more consequential since the patients are younger.

Instead of using traditional chemotherapy and radiation regimens, standard doses of chemotherapy drugs have shown HPV-associated cancers shrink quicker, states Siegel.
 

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Clinical Interchange™: Translating Research to Inform Changing Paradigms: Assessment of Emerging Immuno-Oncology Strategies and Combinations across Lung, Head and Neck, and Bladder CancersOct 31, 20182.0
Community Practice Connections™: Precision Medicine for Community Oncologists: Assessing the Role of Tumor-Testing Technologies in Cancer CareNov 30, 20181.0
Publication Bottom Border
Border Publication
x